| HYLORIS PHARMA. S.A. |
| Belgien |
| Gesundheit |
| BE0974363955 / A2P7Y0 |
| 52U (Frankfurt) |
| FRA:52U, ETR:52U, 52U:GR |
| - |
| https://hyloris.com/ |
|
Hyloris Pharmaceuticals SA is a specialty biopharmaceutical company dedicated to addressing unmet medical needs by innovating, reformulating, and repurposing existing medications. The company leverages established regulatory pathways, such as the FDA..
>Volltext.. |
| 142.74 Mio. EUR |
| 130.66 Mio. EUR |
| 7.33 Mio. EUR |
| -8.78 Mio. EUR |
| -6.44 Mio. EUR |
| -0.23 EUR |
| 1.73 Mio. EUR |
| 14.02 Mio. EUR |
| -6.71 Mio. EUR |
| 2.68 |
| -14.79% |
| 0.13% |
| - |
| - |
| - |
| - |
| HYLORIS |
| 04.04.26 |
|
||||
|
||||
|